MarketCap
Aldeyra Therapeutics ALDX
$ 0.64
4.92%
Facebook
X
Telegram
Aldeyra Therapeutics EV/EBITDA Ratio | ALDX
Annual EV/EBITDA Ratio Aldeyra Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -8.12 | -4.76 | -2.66 | -5.54 | 0.0725 | -9.26 | -2.07 | -3.64 | -4.54 | -2.83 | -2.35 | -5.35 | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.0725 | -9.26 | -4.26 |
EV/EBITDA Ratio of other stocks in the Biotechnology industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Seer
SEER
|
0.144 | $ 1.63 | 0.18 % | $ 90.4 M |  USA |
 |
Gracell Biotechnologies
GRCL
|
2.07 | - | - | $ 3.37 B |  China |
 |
Stoke Therapeutics
STOK
|
-106 | $ 26.51 | 1.69 % | $ 1.57 B | USA |
 |
Sutro Biopharma
STRO
|
-2.84 | $ 9.57 | 4.08 % | $ 81.3 M | USA |
 |
Silence Therapeutics plc
SLN
|
-48.1 | $ 19.73 | 0.03 % | $ 2.8 B |  Britain |
 |
Taysha Gene Therapies
TSHA
|
-11.3 | $ 4.34 | 6.11 % | $ 1.39 B | USA |
 |
Soligenix
SNGX
|
-0.18 | $ 0.34 | 0.54 % | $ 1.76 M | USA |
 |
Spruce Biosciences
SPRB
|
-0.252 | $ 46.46 | 8.78 % | $ 35.6 M | USA |
 |
Supernus Pharmaceuticals
SUPN
|
115 | $ 26.14 | -2.24 % | $ 1.48 B | USA |
 |
Galapagos NV
GLPG
|
5.67 | - | - | $ 1.83 B |  Belgium |
 |
Savara
SVRA
|
-9.6 | $ 4.82 | 9.93 % | $ 1.07 B | USA |
 |
Viking Therapeutics
VKTX
|
-7.87 | $ 26.86 | 4.15 % | $ 3.03 B | USA |
 |
Teligent, Inc.
TLGT
|
2.8 | - | -13.85 % | $ 16.1 M | USA |
 |
Viela Bio, Inc.
VIE
|
-1.96 | - | - | $ 2.91 B | USA |
 |
TG Therapeutics
TGTX
|
37.9 | $ 59.78 | 3.1 % | $ 8.63 B | USA |
 |
Aphria Inc.
APHA
|
-117 | - | -0.45 % | $ 4.87 B |  Canada |
 |
Aerpio Pharmaceuticals, Inc.
ARPO
|
-3.41 | - | -0.90 % | $ 104 M | USA |
 |
Chiasma, Inc.
CHMA
|
-2.73 | - | -6.00 % | $ 238 M | USA |
 |
Wave Life Sciences Ltd.
WVE
|
-9.94 | $ 3.37 | 4.66 % | $ 568 M |  Singapore |
 |
Adamas Pharmaceuticals, Inc.
ADMS
|
-5.12 | - | - | $ 376 M | USA |
 |
Cellect Biotechnology Ltd.
APOP
|
27.1 | - | 0.38 % | $ 12.9 M |  Israel |
 |
AzurRx BioPharma, Inc.
AZRX
|
-0.000002 | - | 2.07 % | $ 34.4 M | USA |
 |
Cerecor Inc.
CERC
|
-4.65 | - | -1.68 % | $ 283 M | USA |
 |
Constellation Pharmaceuticals, Inc.
CNST
|
-11.6 | - | - | $ 1.63 B | USA |
 |
Auris Medical Holding Ltd.
EARS
|
0.463 | - | -1.77 % | $ 39.2 M |  Bermuda |
 |
Dicerna Pharmaceuticals, Inc.
DRNA
|
-14.4 | - | 0.34 % | $ 2.98 B | USA |
 |
ERYTECH Pharma S.A.
ERYP
|
5.22 | - | 1.3 % | $ 27.7 M |  France |
 |
GW Pharmaceuticals plc
GWPH
|
-110 | - | - | $ 6.81 B | Britain |
 |
Kadmon Holdings, Inc.
KDMN
|
-7.37 | - | - | $ 1.7 B | USA |
 |
Liminal BioSciences
LMNL
|
-0.811 | - | - | $ 256 M | Canada |
 |
argenx SE
ARGX
|
38.2 | $ 928.5 | 3.77 % | $ 56.9 B |  Niderland |
|
XBiotech
XBIT
|
0.841 | $ 1.88 | 0.53 % | $ 57.3 M | USA |
 |
Neos Therapeutics, Inc.
NEOS
|
-17.5 | - | -2.54 % | $ 57.2 M | USA |
 |
Xencor
XNCR
|
-6.45 | $ 36.19 | 6.28 % | $ 2.69 B | USA |
 |
Odonate Therapeutics, Inc.
ODT
|
-4.74 | - | -3.18 % | $ 58.5 M | USA |
 |
Orphazyme A/S
ORPH
|
0.718 | - | -2.25 % | $ 31.3 M |  Danmark |
 |
Osmotica Pharmaceuticals plc
OSMT
|
16.1 | - | -10.74 % | $ 89.9 M | USA |
 |
Pandion Therapeutics, Inc.
PAND
|
-11.2 | - | - | $ 1.77 B | USA |
 |
Xenetic Biosciences
XBIO
|
0.897 | $ 1.87 | 0.31 % | $ 3.18 M | USA |
 |
Translate Bio, Inc.
TBIO
|
350 | - | - | $ 2.81 B | USA |
 |
Trillium Therapeutics Inc.
TRIL
|
-14 | - | - | $ 1.94 B | Canada |
 |
Exicure
XCUR
|
-8.87 | $ 0.91 | 2.77 % | $ 5.73 M | USA |
 |
Urovant Sciences Ltd.
UROV
|
-1.91 K | - | - | $ 532 M | Britain |
 |
Acceleron Pharma Inc.
XLRN
|
-47 | - | - | $ 10.9 B | USA |
 |
Zealand Pharma A/S
ZEAL
|
-0.823 | - | 0.52 % | $ 821 M | Danmark |
 |
Zogenix, Inc.
ZGNX
|
-4.47 | - | -4.97 % | $ 664 M | USA |
|
Yunhong International
ZGYH
|
44 | - | 0.10 % | $ 92.2 M | China |
 |
ZIOPHARM Oncology, Inc.
ZIOP
|
-8.58 | - | -7.58 % | $ 264 M | USA |
 |
Xenon Pharmaceuticals
XENE
|
-6.03 | $ 39.02 | 3.56 % | $ 3.09 B | Canada |
 |
Leap Therapeutics
LPTX
|
0.106 | - | 368.57 % | $ 41.9 M | USA |